Specifically, in animal models of atherosclerosis, namely, ApoE−/− and LDL receptor−/− knockout mice, GLP‐1 treatment reduced plaque size (Bjørnholm et al., 2020). The gene discussed is GLP1R; the disease is atherosclerosis.